Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | THC | Common Stock | Options Exercise | +5.6K | +25.73% | 27.4K | Mar 1, 2024 | Direct | F2 | ||
transaction | THC | Common Stock | Tax liability | -$208K | -2.2K | -8.05% | $94.29 | 25.1K | Mar 1, 2024 | Direct | F3, F4 |
transaction | THC | Common Stock | Sale | -$374K | -3.98K | -15.81% | $94.03 | 21.2K | Mar 1, 2024 | Direct | F5 |
transaction | THC | Common Stock | Sale | -$942K | -9.93K | -46.88% | $94.96 | 11.2K | Mar 1, 2024 | Direct | F6 |
transaction | THC | Common Stock | Sale | -$296K | -3.1K | -27.55% | $95.48 | 8.15K | Mar 1, 2024 | Direct | F7 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | THC | 2023 March Restricted Stock Units | Options Exercise | $0 | +5.6K | +99.96% | $0.00 | 11.2K | Mar 1, 2024 | Common Stock | 5.6K | Direct | F1 |
Id | Content |
---|---|
F1 | The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on March 1, 2024. |
F2 | Restricted stock units convert into common stock on a one-for-one basis. |
F3 | Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. |
F4 | Represents the closing price of the common stock of the Issuer on March 1, 2024. |
F5 | The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $93.395 to $94.39. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
F6 | The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $94.395 to $95.37. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
F7 | The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $95.40 to $95.62. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |